ATP5MK and hepatocellular carcinoma: The aim of this analysis is to develop a mass spectrometric platform to determine the alterations in N-glycan structures of serum AGP between HCC and liver cirrhosis patients in various etiologies, and to further evaluate whether the altered glycosylation patterns of AGP could serve as a marker for early detection of HCC.